(25.5%) mentioned at least one reporting guideline, with CONSORT the most frequently cited. Journals with high impact factors were more likely to endorse CONSORT (p ! 0.009). Other reporting guidelines were mentioned by ! 6% of the journals. Conclusion: All key stakeholders involved in the publication process should more frequently promote the awareness and use of reporting guidelines.
Introduction
Clinical studies are a key element of biomedical research and adequate reporting is essential for the translation of findings into clinical practice [1] . Therefore, publications should describe aims, methods, and results in a transparent and complete manner. Deficiencies in the reporting of scientific studies may have serious implications for patients and health systems [2, 3] . In recent decades, several initiatives have been established to improve this situation.
The International Committee of Medical Journal Editors (ICMJE) was established in 1978 to provide guidance for preparing biomedical manuscripts. A general guideline, Uniform Requirements for Manuscripts Submitted to Biomedical Journals (URM), was published to improve reporting. In addition, ethical principles related to the publication of manuscripts in biomedical journals were incorporated. These requirements addressing authors and reviewers have been revised recently [4] .
Over the last 15 years, a number of reporting guidelines for specific study designs have been published to improve the completeness of research reporting [5, 6] by specifying a minimum set of information required to understand the trial methodology and to interpret the findings [7] . The first guideline, the CONSORT (CONsolidated Standards Of Reporting Trials) statement, was developed to increase the reporting quality of randomized controlled trials; it was first published in 1996, revised in 2001, and updated in 2010 [8, 9] . Reporting guidelines are also available for various other study designs, including diagnostic test accuracy studies (STAndards for Reporting Diagnostic accuracy, STARD) [10] , observational studies (STrengthening the Reporting of OBservational studies in Epidemiology, STROBE) [11] , genetic association studies (STrengthening the REporting of Genetic Association studies, STREGA) [12] , non-randomized trials (Transparent Reporting of Evaluations with Nonrandomised Designs, TREND) [13] , Meta-analysis Of Observational Studies in Epidemiology (MOOSE) [14] , and systematic reviews of randomized controlled trials (Preferred Reporting Items for Systematic reviews and Meta-Analyses, PRISMA) [15] . Other reporting guidelines such as COREQ (COnsolidated criteria for REporting Qualitative research) and SQUIRE (Standards for QUality Improvement Reporting Excellence) aim to improve the reporting of qualitative research and quality improvement studies, respectively [16, 17] . In 2008, an international collaboration (Enhancing the QUality And Transparency Of health Research, EQUATOR) was founded to increase the awareness of reporting guidelines, to provide support for their development, and to maintain up-to-date information on health research reporting [18, 19] . All relevant guidelines are available on the website of the EQUATOR network (www.equatornetwork.org/).
As reporting guidelines are considered helpful tools in ensuring the availability of relevant information in manuscripts, we set out to assess the extent to which references to reporting guidelines are incorporated in the author instructions of journals in the field of urology.
Materials and Methods
This survey focused on journals relevant to the field of urology. We accessed the 'Journal Citation Reports 2009' [20] , identified all journals indexed in the subject categories 'Urology and Nephrology' and 'Andrology' (11/2010) , and downloaded author instructions from the journal websites (12/2010). We did not impose any language restrictions.
The author instructions of these journals were analyzed in a two-step approach. First, we checked whether the journals published original research investigations. Journals exclusively reporting commissioned articles or expert reviews were excluded. Journals that ceased publication after 2009 were included only if sufficient information (author instructions) was still available online. If two or more journals referred to the same author instructions, they were treated as independent journals for evaluation.
Second, we evaluated whether the URM or any reporting guidelines were mentioned. If the URM were mentioned, we evaluated the context in which they appeared in the author instructions. If the URM were mentioned only for advice regarding trial registration, conflict of interest, or reference style, we classified its occurrence as 'not relevant'. If the URM were referred to generally or in the context of manuscript preparation, the occurrence was classified as 'relevant'.
We extracted information on the CONSORT [9] , STROBE [11] , STARD [10] , TREND [13] , MOOSE [14] , PRISMA/QUO-ROM [15] , STREGA [12] , COREQ [17] , and SQUIRE [16] guidelines, but we also included any other reporting guideline mentioned specifically by the journal. The QUOROM (QUality Of Reporting Of Meta-analyses) guideline was updated and renamed PRISMA in 2009 [15] ; for this analysis, we classified QUOROM as a subgroup of PRISMA. We also determined whether author instructions mentioned the EQUATOR network as an additional resource for manuscript preparation. We defined editorial advice on manuscript preparation as any endorsement of reporting guidelines and/or URM in the context of general manuscript preparation.
Two authors (F.K., H.G.) independently read each author guideline and used relevant key words (report, guideline, checklist, CONSORT, STROBE, STARD, MOOSE, PRISMA, QUO-ROM, TREND, SQUIRE, STREGA, COREQ, international, committee, uniform, EQUATOR) in electronic full-text searches to identify information on the endorsement of the URM and reporting guidelines. One author (F.K.) checked the assessments for discrepancies, which were then resolved by re-checking the respective websites and by discussion with a third author (J.M.).
We retrieved additional information about publication language and country of journals from the database 'Journals in NCBI Databases' in the National Library of Medicine via PubMed (02/2011). The information available for the entry 'author(s)' was used to identify whether a journal was the official publication forum of a medical association.
Impact factors of selected journals were compared using the nonparametric Wilcoxon rank-sum test for continuous variables. For the assessment of relationships among endorsement of any reporting guideline or URM, medical associations, publication language, and country of publication, we used a multiple logistic regression model. All statistical tests were two-sided, and p ! 0.05 was considered significant.
.
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Results
We identified 69 journals ('Urology and Nephrology', n = 63; 'Andrology', n = 6), of which 14 journals were excluded ( fig. 1 ) to include 55 journals in the final evaluation. All journals published their editorial scope on their website and offered links to author instructions. The impact factor of the journals ranged from 0.054 to 7.689.
The recommendations of the ICMJE (URM) were mentioned by 32 journals (58.2%; table 1 ). However, 20 of these 32 journals (62.5%) mentioned this guideline exclusively in the context of trial registration, conflict of interest, or style of references (n = 4 (20%), n = 7 (35%), and n = 9 (45%), respectively) and were therefore classified as 'not relevant'. Only 12 of the 32 journals (37.5%) men- a URM was mentioned for general manuscrip t/style preparation.
b URM was mentioned for trial registration, conflict of interest, or reference preparation. CONSORT = Consolidated standards of reporting trials; COREQ = consolidated criteria for reporting qualitative research; EQUATOR = enhancing the quality and transparency of health research; IF = impact factor; MOOSE = meta-analysis of observational studies in epidemiology; PRISMA = preferred reporting items for systematic reviews and meta-analysis of randomized controlled trials; QUOROM = quality of reporting of meta-analysis; STARD = standards for reporting diagnostic accuracy; STREGA = strengthening the reporting of genetic association studies; STROBE = strengthening the reporting of observational studies in epidemiology; SQUIRE = standards for quality improvement reporting excellence; TREND = transparent reporting of evaluations with non-randomized designs; URM = uniform requirements for manuscripts.
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Urol Int 2012;88:54-59 57 tioned the URM in order to give general advice about manuscript preparation and were therefore classified as 'relevant'. Fourteen journals (25.5%) mentioned at least one reporting guideline ( table 1 ) , with the CONSORT statement referred to most frequently (13 journals, 92.8%). Journals with higher impact factors were more likely to endorse the CONSORT statement than journals with lower impact factors (p ! 0.009): six of seven journals (85.7%) with impact factors 1 4.0 endorsed the CONSORT statement compared to 13.3-16.7% of journals with impact factors ! 4.0 (impact factors 2.01-4.0, n = 3, 16.7%; impact factors 0.01-2.0, n = 4, 13.3%).
Other reporting guidelines such as MOOSE, PRIS-MA/QUOROM, STARD, and STROBE were endorsed by only three journals (5.4%) each, while the checklist SQUIRE was endorsed by two journals (3.6%). TREND, STREGA, COREQ, and the Case Report Checklist were each endorsed by one journal (1.8%), as was the EQUA-TOR network (1.8%). However, this reference was buried within the reference for the SQUIRE checklist and was not referenced for additional advice on manuscript preparation. One journal mentioned an additional guideline, the 'Analytical reporting checklist for authors', for reporting of animal experiments, cohort studies, or randomized trials. QUOROM was mentioned by one journal despite being obsolete.
Twenty journals (36.4%) mentioned at least one reporting guideline or the URM in their author instructions ( table 1 ) . Of these, 13 journals mentioned the CON-SORT statement, six endorsed the URM without mentioning other reporting guidelines, and one journal mentioned an additional guideline without referring to the CONSORT statement or the URM. Three journals mentioned more than two reporting guidelines in addition to the URM (range 5-8). All journals with impact factors 1 4.0 (n = 7; 100%) endorsed at least one reporting guideline or the URM, while journals with lower impact factors were more likely to not mention the URM or other reporting guideline (impact factors 2.01-4.0, 5/18 journals, 27.8%; impact factors 0.01-2.0, 8/30 journals, 26.7%). Although the likelihood of endorsement of any reporting guideline seems to increase in parallel with the impact factor of the journal, this trend was not statistically significant (Wilcoxon rank sum test, p ! 0.057).
Thirty-six of 55 journals (65.5%) were used by medical associations as official publication fora. Of the 20 journals that mention at least one reporting guideline or the URM, 17 (85%) were associated with at least one medical association. The majority of journals (n = 48; 87.3%) were published in English, of which 18 endorsed at least one reporting guideline or the URM (37.5%). Of the remaining seven journals (12.7%) published in a language other than English (two in German, three in French, two in Spanish), five journals did not mention any reporting guideline (71.4%). However, the variables included in the exploratory regression model (medical association, publication language, and country of publication) had no statistically significant influence on the endorsement of reporting guidelines or the URM ( table 2 ) .
Discussion
When we analyzed whether the author instructions of journals relevant to urology provided editorial advice about reporting guidelines, we discovered that only 36.4% of the evaluated journals mentioned at least one reporting guideline or the URM in their author instructions ( table 1 ). The URM was mentioned most often, followed by the CONSORT statement, which was referred to most frequently out of the set of reporting guidelines. Other reporting guidelines were mentioned only rarely. Journals with higher impact factors tended to refer to reporting guidelines more often than journals with lower impact factors.
Previous studies have demonstrated that the trial-reporting quality in the field of urology could be improved [21] [22] [23] , and that reporting guidelines can improve reporting quality [5, 24, 25] . Our identification of the low proportion of journals endorsing reporting guidelines is in agreement with studies in other specialties. For exam- ple, Meerpohl et al. [26] showed that the general endorsement of reporting guidelines was low for pediatric journals; while CONSORT was referenced most frequently (20% of all selected pediatric journals), all other guidelines were referenced by less than 10% of those journals. Hopewell et al. [27] evaluated 165 medical journals with high impact factors and determined that CONSORT was mentioned in 38% of those journals. It is obvious that authors carry the main responsibility for their manuscripts, and it is their obligation to prepare their research articles in an accurate, transparent, and complete manner so that all the information important for data interpretation is available. However, it cannot be assumed that all authors possess the relevant skills or tools to prepare high-quality articles. We suspect that some authors may not even be aware of reporting guidelines at all. Therefore, and because it is in their own best interest, it seems reasonable to expect journals to refer to reporting guidelines that help ensure good reporting quality. It could be argued that research articles go through peer-review and that this process helps to ensure high scientific quality. However, it is unclear whether the peer-review process is sufficient to guarantee completeness and accuracy of funded research [28] and good reporting quality.
Medical associations promote and coordinate research in their fields and seek to increase the implementation of validated treatments. It was therefore not surprising that 85% of the journals that endorsed relevant reporting guidelines were used by medical associations as an official publication forum. On the other hand, it was disappointing to observe that only half of all journals used as a publication forum by medical associations endorsed at least one reporting guideline or the URM. It is in the interest of medical associations to ensure high-quality reporting of studies in their affiliated journals and to increase research transparency in general. Medical associations may have the power to influence the editorial policies of affiliated journals and, in our opinion, should request the endorsement of reporting guidelines more frequently and forcefully. Empirical studies have revealed that a requirement for the use of reporting guidelines can increase reporting quality [5, 21] .
There are some limitations to our study. We know that not all journals in the field of urology are indexed in the 'Journal Citation Reports 2009'. It should therefore be kept in mind that this evaluation is probably not fully representative of all existing urology journals. Assuming that there is a quality gradient for indexed versus nonindexed journals in 'Journals Citation Reports', the overall endorsement of reporting guidelines in the field of urology may even be worse. A further limitation of this study is that we did not assess whether editors or reviewers recommended the guidelines to authors during the submission and/or review processes. However, we assume that this is not a very common practice.
The transparent and complete reporting of research studies is an important cornerstone of knowledge translation. Even an excellently designed and conducted trial is only of limited value if it is inadequately reported. The reporting quality in the field of urology could be increased if more journals endorsed reporting guidelines, which aim to ensure adequate and complete reporting of clinical studies. Aspects of good publication practice such as the use of reporting guidelines have been promoted for years now. However, the uptake and implementation by journals publishing in the field of urology is in general still insufficient. The key stakeholders involved in the publication process should promote the awareness and use of reporting guidelines more comprehensively.
